Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Condition Approved
For
AZD3293 LY3314814,
BACE inhibitor
2/3 AstraZeneca, Eli Lilly & Co. Amyloid-Related Small Molecule Alzheimer's Disease
CNP520 BACE Inhibitor 2/3 Amgen, Inc., Novartis Pharmaceuticals Corporation Amyloid-Related Small Molecule Alzheimer's Disease
JNJ-54861911 BACE inhibitor 2/3 Janssen, Shionogi Pharma Amyloid-Related Small Molecule Alzheimer's Disease
Thalidomide Thalomid® 2/3 Celgene Corporation Amyloid-Related, Inflammation Small Molecule Alzheimer's Disease